Psychemedics (PMD) Declares $0.18 Quarterly Dividend; 5.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Psychemedics (PMD) Reports Q1 EPS of $0.11 on Revenues of $9.8M
April 23, 2019 5:34 PM EDTPsychemedics (NASDAQ: PMD) reported Q1 EPS of $0.11, versus $0.23 reported last year. Revenue for the quarter came in at $9.8 million, versus $10.9 million reported last year.
Raymond C. Kubacki, Chairman and Chief Executive Officer, stated:
"First quarter revenues and earnings were below expectations, and continued to be impacted by negative changes in the Brazilian foreign currency exchange rate.
International revenues showed a decline. While the Driver segment showed some weakness, this was compounded by a decline in the more cyclical Non-Driver business and the negative foreign currency exchange. Our domestic... More
